Ozempic or retirement? Some users are sacrificing savings to pay for prescriptions.

(NewsNation) — Americans taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may be facing a new financial dilemma: save for retirement or pay for the drugs helping improve their health. A new survey from the Nationwide Retirement Institute found that 51% of current GLP-1 users worry they may have to choose between medication costs and retirement savings.
The survey suggests those concerns are already affecting financial decisions. According to Nationwide, 54% of current